The immunological synapse (IS) is a cell-cell junction formed between CD4 + T cells and dendritic cells (DCs). Here we show in vitro and in vivo that IS formation inhibits apoptosis of DCs. Consistent with these results, IS formation induced antiapoptotic signaling events, including activation of the kinase Akt1 and localization of the prosurvival transcription factor NF-jB and the proapoptotic transcription factor FOXO1 to the nucleus and cytoplasm, respectively. Inhibition of phosphatidylinositol 3-OH kinase and Akt1 partially prevented the antiapoptotic effects of IS formation. Direct stimulation of the IS component CD40 on DCs leads to the activation of Akt1, suggesting the involvement of this receptor in the antiapoptotic effects observed upon IS formation.
The immunological synapse (IS) is a cell-cell junction formed between CD4 + T cells and dendritic cells (DCs). Here we show in vitro and in vivo that IS formation inhibits apoptosis of DCs. Consistent with these results, IS formation induced antiapoptotic signaling events, including activation of the kinase Akt1 and localization of the prosurvival transcription factor NF-jB and the proapoptotic transcription factor FOXO1 to the nucleus and cytoplasm, respectively. Inhibition of phosphatidylinositol 3-OH kinase and Akt1 partially prevented the antiapoptotic effects of IS formation. Direct stimulation of the IS component CD40 on DCs leads to the activation of Akt1, suggesting the involvement of this receptor in the antiapoptotic effects observed upon IS formation.
Immune responses are initiated by the specific interaction of T cells and DCs in the lymph nodes [1] [2] [3] . During this process a specialized cellcell junction called immunological synapse is formed between these two cell types [2] [3] [4] [5] [6] [7] [8] . We will use the terms IS(T cell) and IS(DC) to refer to the IS region on the T cell and DC side, respectively. The IS(DC) includes receptors such as the integrin LFA-1 (a L b 2 ) 2-8 and the co-stimulatory molecule CD40 (A000031) 9 .
Despite the many studies on the IS 2,10-12 , the functions of this structure are still controversial 12, 13 . The IS(T cell) influences T cell antigen receptor (TCR) signaling and T cell activation 14, 15 , as well as endocytosis of the TCR 15 , polarized secretion of T cell cytokines toward the antigen-presenting cell (APC) 16 and the lineage commitment of naive CD4 + T cells 17 . Fewer studies have analyzed the IS(DC) and its possible contribution to the functions of the IS 3 . However, the existence of specific counter-receptors on the IS(DC) that mirror surface molecules on the IS(T cell) 18 , and the observed polarization of F-actin at the IS(DC) 19 , suggest that this region may behave as a signaling platform and may regulate DC functions.
Apoptosis is a process involved in development, elimination of damaged cells, and the maintenance of cell homeostasis [20] [21] [22] [23] . Many receptors inhibit apoptosis by inducing activation of phosphatidylinositol 3-OH kinase (PI(3)K) and its downstream effector kinase Akt1 (A000249) 20, 22 . Active Akt1 controls a variety of molecules, and its activity prevents apoptosis and extends cell survival 20, 22 . Among the important downstream effectors of Akt1 are Bcl-2 family members 20, 23 . Specifically, Akt1 promotes translocation of the transcription factor NF-kB to the nucleus, where NF-kB induces transcription of genes encoding antiapoptotic Bcl-2 family members 24 . Furthermore, Akt1 phosphorylates and inactivates the Forkhead box class O (FOXO) family of transcription factors, which includes FOXO1 (A000944), FOXO3a and FOXO4. Upon phosphorylation by Akt1, FOXO proteins are inactivated because they shuttle from the nucleus to the cytoplasm, where they are either retained by the 14-3-3 linker or degraded 22, 25, 26 . FOXO members can activate transcription of genes encoding proapoptotic molecules, including proapoptotic Bcl-2 member Bim 22, 25, 26 , a key regulator of apoptosis 21, 23 . Therefore, FOXO inactivation may also contribute to cell survival.
In the lymph node, antigen-loaded DCs induce activation of T cells that express cognate TCRs. Unlike T cells, which after activation and proliferation exit the lymph node, mature DCs undergo apoptosis in the lymph node 21, 27, 28 . However, activation of T cells by DCs, after IS formation, requires several hours of contact between these cells 4, 6, 7, 29, 30 . Thus, regulation of DC survival during this period is likely to be important. We hypothesized that the IS(DC) might operate as a molecular transducer of intracellular signals that inhibit DC apoptosis.
RESULTS

IS formation inhibits DC apoptosis in vitro
We wanted to test the hypothesis that IS formation confers extended survival upon DCs. Two observations facilitated the experimental investigation. First, after in vitro induction of IS formation in complete medium (10% FCS in RPMI), transfer of DC-T cell conjugates to 0.1% BSA in RPMI did not affect, for at least 10 h, the percentage of conjugates forming IS (data not shown). Second, under serum-free conditions, DCs had a much higher susceptibility to apoptosis than did CD4 + T cells (Fig. 1) . For example, when we maintained human DCs or CD4 + T cells in 0.1% BSA in RPMI for 10 h and then measured the percentage of cells displaying the apoptosis indicators nucleus condensation or phosphatidylserine externalization 31 , the percentage of apoptotic cells was significantly higher in DC than T cell populations (Fig. 1a,b) . We also observed this greater tendency of human DCs to become apoptotic under serum-free conditions when antigen-loaded DCs were compared to antigen-specific or non-antigen-specific human CD4 + T cells (Fig. 1c) .
To test whether IS formation protected DCs from apoptosis in vitro, we first induced IS formation between DCs and CD4 + T cells in complete medium by sedimenting, through centrifugation, a mixture of DCs and CD4 + T cells 17, 19 . Next we transferred single DCs and DC-T cell conjugates forming an IS to 0.1% BSA in RPMI for additional 10 h. At the end of this period, we analyzed by immunofluorescence the percentage of DCs that showed phosphatidylserine externalization or nuclear condensation. In a first set of experiments (Fig. 2a) , we allowed allogeneic interactions between unpulsed human DCs and resting polyclonal memory CD45RO + CD4 + T cells (hereafter called CD4 T cells) or naive CD45RA + CD4 + T cells (CD4-naive). In a second set of experiments (Fig. 2b) , we induced autologous interactions between purified protein derivative (PPD)-pulsed DCs and PPDspecific polyclonal CD4 T cells, PPD-pulsed DCs and non-antigenspecific polyclonal CD4 T cells, or tetanus toxoid-pulsed DCs and PPD-specific polyclonal CD4 T cells. The percentage of cells that underwent apoptosis was reduced almost 60% in DCs that formed IS, compared to single DCs (Fig. 2a,b) . Taken together, these results indicate that IS formation protects DCs from apoptosis.
In the immunofluorescence experiments, we also observed consistent protection from apoptosis when DCs forming an IS were compared to unengaged DCs in the same fields of view; that is, when all DCs were probably exposed to similar concentrations of soluble factors. However, to completely rule out the possibility that the observed protection was due to soluble factors secreted by the cells and not by IS formation, we performed experiments in which human T cells and DCs were separated by a Transwell membrane that allowed only the passage of soluble factors (Fig. 2c) . A higher percentage of DCs incubated alone or separated from T cells by a membrane underwent apoptosis, compared to DCs that formed an IS (Fig. 2c) . The results indicate that soluble factors are not sufficient to induce the observed inhibition of DC apoptosis. Protection from apoptosis was also observed when mouse splenic DCs pulsed with ovalbumin (OVA) peptide formed ISs with mouse OVA peptide-specific OTII CD4 T cells ( Supplementary Figs. 1 and 2 online), indicating that the protective effect of the IS is conserved between these species. Finally, IS disruption induced by treatment with a blocking LFA-1-specific antibody 32 led to an increase in the percentage of apoptotic DCs ( Supplementary Fig. 3 online) . As all types of IS analyzed here suppressed DC apoptosis, all subsequent experiments were carried out with human DCs and memory CD4 T cells that established allogeneic interactions, unless otherwise indicated.
IS formation inhibits apoptosis of DCs in lymph nodes
To identify apoptotic DCs inside the lymph node, we used FLIVO. This reagent 33 , Val-Ala-Asp (O-methyl)-fluoromethylketone (VAD-FMK) conjugated to a fluorescent dye, binds irreversibly to caspases, including caspases 1, 3, 4, 5, 6, 7, 8 and 9 , that are activated during apoptosis 20 . Thus FLIVO can be used as a probe to detect apoptotic cells 33 . In this regard, FLIVO and Hoechst stain are equivalent in their ability to distinguish apoptotic from nonapoptotic cells 34 ( Supplementary Fig. 4 online). As the fluorophore-conjugated forms of FLIVO are cell permeant and chemically stable, this reagent can be injected intravenously in mice to detect apoptotic DCs in the lymph nodes. Nonapoptotic DCs, which lack active caspases, remain largely unlabeled because fluorescent FLIVO diffuses out of these cells ( Supplementary  Fig. 5 online) . In contrast, fluorescent FLIVO binds irreversibly to caspases upregulated in apoptotic cells, allowing the selectively labeling of these cells in the lymph node ( Supplementary Fig. 5 ). Fluorescently labeled DCs can be subsequently examined inside the lymph node by two-photon microscopy ( Fig. 3 and Supplementary Fig. 5 ).
Using FLIVO, we analyzed whether IS formation was able to protect DCs from becoming apoptotic in the lymph node (Fig. 3a) . C57BL/6 mice were injected subcutaneously in the hind footpad with Nomarski Hoechst Figure 1 DCs show a higher tendency to become apoptotic than CD4 7 (data not shown), mice were injected in the tail vein with SNARF1-labeled OTII CD4 T cells and left for another 17 h. After this period, mice were injected intravenously with sulforhodamine-conjugated FLIVO and, after 1 h, put to death. The popliteal lymph nodes were resected and subsequently analyzed by two-photon microscopy. Experiments performed in parallel showed that the percentage of apoptotic CD4 T cells in the lymph node was negligible under these conditions (Fig. 3c,d ). However, in the same injection experiment and the same lymph node, compared to single DCs (that is, those not forming contacts with CD4 T cells), a lower percentage of apoptosis was observed in DCs forming an IS with T cells (Fig. 3b,d ). To rule out the possibility that the extended DC survival observed was the consequence of the selection of healthier DCs that may preferentially form an IS in the same lymph node, we compared the total percentage of live DCs (that is, the percentage of live unengaged DCs plus the percentage of apoptosis live DCs forming an IS) in lymph nodes of mice that were injected only with CMFDA-DCs, and that consequently did not form ISs in the lymph nodes, to mice that were injected with both CMFA-DCs and OTII CD4 T cells, and thus can form ISs in this location. IS formation resulted in a lower percentage of total apoptotic DC in vivo (Supplementary Fig. 6 online) . In sum, these results showed that IS formation inhibits the apoptosis of DCs in the lymph node.
IS formation induces activation of Akt1 at the IS(DC)
Next we induced IS formation between human DCs and CD4 T cells, and used a phosphotyrosine-specific mAb (Py20) and phalloidin-FITC to analyze by immunofluorescence the presence of phosphorylated proteins and F-actin at the IS(DC). We observed an intense phosphotyrosine staining in the IS(DC) region of DCs that formed an IS, suggesting that this was an active signaling region (Fig. 4a) . In agreement with previous results 19 , we observed strong F-actin staining at the IS(DC) region (Fig. 4a) . Single DCs did not show accumulation of F-actin or phosphotyrosine in any particular region of the membrane (Fig. 4a) . We also observed F-actin and phosphotyrosine accumulation at the IS(DC) when OVA peptide-pulsed mouse splenic DCs were allowed to form an IS with OVA peptide-specific OTII CD4 T cells ( Supplementary Fig. 7 online). As Akt1 regulates cell survival in many cell types 20, 22 , we next analyzed whether IS formation could induce activation of Akt1 at the IS(DC) region. Using antibodies that stain phosphorylated, active Akt1, we observed by immunofluorescence that there was an intense staining of this active Akt1 at the IS(DC) region (Fig. 4b) . In contrast, in single DCs, active Akt1 was distributed in a weakly stained rim around the membrane. Activation of Akt1 requires its translocation to the plasma membrane via its PH domain 22, 35, 36 . To study whether IS formation induces mobilization of Akt to the IS(DC) region, we transfected human DCs either with a GFP vector or with a construct encoding the PH domain of Akt1 (Akt1-PH-GFP), which recognizes phosphatidylinositol (3,4,5)-trisphosphate on the membrane 35 . The transfected DCs were mixed with allogeneic human CD4 T cells and plated onto fibronectin-coated dishes, and formation of IS between the T cells and the transfected DCs was followed by videomicroscopy. We then fixed the transfected DCs with paraformaldehyde and quantified the percentage of DCs that showed vector-GFP or Akt1-PH-GFP staining at the IS(DC). IS formation resulted in enhanced Upper: translocation of Akt1-PH-GFP to the IS(DC) region, where it was maintained for at least 90 min (Fig. 4c,d and Supplementary Fig. 8 online). In the DCs transfected with vector-GFP, the percentage of DCs that showed GFP in the IS(DC) region was much lower (Fig. 4c,d ). These results indicate that IS(DC) formation induces signaling, including activation of Akt1, in this region.
As treatment of DC-T cell conjugates with the PI(3)K inhibitors LY294002 or wortmannin does not disrupt completely the IS formed between DCs and T cells 36 , we took advantage of this observation to analyze the contribution of PI(3)K and Akt to the antiapoptotic function of the IS(DC). We reasoned that if PI(3)K and its downstream kinase Akt1 were the only contributors to the prosurvival effects of the IS(DC), then the inhibition of these kinases in DCs would cause the DCs to undergo apoptosis even when forming an IS with T cells. To analyze this issue directly, single DCs and DCs that had formed an IS were transferred to serum-free medium. Subsequently, half of these cells were treated with LY294002 for 6 h and the other half were kept untreated for a similar period. Control experiments showed that treatment with LY294002 completely inhibited the phosphorylation of Akt1 in DCs (Fig. 5a) . However, despite the treatment with LY294002, almost 60% of preexisting ISs remained intact. Untreated conjugates, by comparison, maintained 100% the ISs formed (data not shown). Consistent with previous experiments (Figs. 1 and 2) , in untreated samples, DCs that formed an IS underwent 47 ± 5.3% less apoptosis than did single DCs (Fig. 5b) . However, in the LY294002-treated samples, IS formation reduced the percentage of DCs Fig. 8 ).
undergoing apoptosis by only 19.8 ± 8% compared to single DCs (Fig. 5b) . These results suggest that the IS confers some degree of protection to the DCs even when Akt is completely inhibited. Despite the high concentration of the inhibitor used, the percentage of apoptotic CD4 T cells remained very low (Fig. 5b) , consistent with results obtained by others 37 , indicating that the apoptosis of DCs forming IS was not due to apoptosis of the T cells. In sum, these results indicate that Akt is important in the antiapoptotic effects of the IS, but that other, unidentified molecules must also contribute to these effects.
IS formation induces NF-jB nuclear localization in DCs NF-kB promotes transcription of prosurvival genes in DCs 22, 24, 31 . As activation of NF-kB correlates with its translocation from the cytoplasm to the nucleus 31,38 , we analyzed whether DCs that formed an IS displayed more of this transcription factor in the nucleus compared to single DCs. We transfected human DCs either with vector-GFP or with a construct encoding GFP-tagged p65, a subunit of the NF-kB family that is expressed in DCs 31, 38, 39 . We then allowed the transfected DCs to form an IS with CD4 T cells. Although 38% of single DCs showed p65-GFP in the nucleus, this percentage rose to 79% in transfected p65-GFP DCs that formed an IS with T cells (Fig. 6) . As a positive control, we stimulated p65-GFP transfected DCs with tumor necrosis factor (TNF) 31, 40 ; 63% of TNF-stimulated DCs displayed strong nuclear GFP fluorescence (Fig. 6) . In contrast, in most vector-GFPtransfected DCs, the fluorescent staining remained in the cytoplasm even in DCs that formed an IS with T cells (Fig. 6) . Similar results were obtained when ISs were formed between p65-GFP-transfected human DCs and naive (CD45RA + ) CD4 T cells. In this case, among the DCs that formed an IS, 72% displayed nuclear p65-GFP staining.
In contrast, only 37% of single DCs showed nuclear p65-GFP fluorescence (data not shown).
FOXO1 controls Bim expression and DC apoptosis
To determine whether FOXO1 regulates apoptosis in human DCs, we knocked down this transcription factor by nucleofecting DCs with a short interfering RNA (siRNA) specific for FOXO1. Immunofluorescence and immunoblotting using anti-FOXO1 showed that, compared to DCs transfected with control siRNA, DCs transfected with FOXO1-specific siRNA had less FOXO1 protein (Fig. 7) . When we transferred siRNA-control or siRNA-FOXO1 transfected DCs to serum-free medium and subsequently analyzed the percentage of apoptotic cells, we observed a significantly lower percentage of apoptosis in the DCs where FOXO1 was knocked-down (Fig. 7b) . These results indicate that under serum-free conditions FOXO1 plays a proapoptotic role in DCs. Bim, a proapoptotic gene controlled by FOXO1 21, 22, 25, 26 , promotes apoptosis in DCs 21, 23 . Consistent with its proapoptotic role, we observed increased expression of Bim in control DCs cultured in serum-free medium (Fig. 7d) . Densitometry showed that Bim expression in DCs cultured for 10 h in 10% FCS RPMI and 0.1% BSA RPMI was onefold and threefold, respectively, the basal Bim expression obtained at time 0 in DCs in 10% FCS RPMI (set as 1). Moreover, compared to siRNA-control DCs, siRNA-FOXO1 DCs expressed less Bim (Fig. 7c) . Thus, under serum-free conditions, Bim may mediate the proapoptotic effects of FOXO1 in DCs. As FOXO1 promotes apoptosis in DCs, we asked whether IS(DC) formation could inhibit FOXO1 in DCs. Inactivation of FOXO1 involves its translocation from the nucleus to the cytoplasm 22, 25, 26 . Therefore, we analyzed whether IS formation induced cytoplasmic localization of FOXO1 in DCs. We transfected vector-GFP or (Fig. 8a,b) . In contrast, more than 70% of DCs forming an IS showed cytoplasmic FOXO1-GFP. A similar percentage of cells with cytoplasmic FOXO1-GFP was found among DCs stimulated with FCS, which were used as positive controls (Fig. 8a,b) . In the vector-GFP-transfected DCs, most of the staining remained in the cytoplasm under all conditions examined (Fig. 8a,b) . The results obtained with the FOXO1-GFP-transfected cells were confirmed by staining for endogenous FOXO1 in untransfected DCs (Fig. 8c) . These immunofluorescence experiments showed that the percentage of DCs with cytoplasmic FOXO1 increased from a 5% in single DCs to almost 15% in DCs that formed an IS ( Fig. 8c and data not shown) . Finally, we confirmed these results using biochemical experiments. DCs were transfected with vector-GFP or with FOXO1-GFP and then were maintained as single cells or allowed to form an IS with T cells. Single DCs or DCs forming an IS were subsequently transferred to serumfree medium for 2 h. After this treatment, we subjected vector-GFP and FOXO1-GFP transfected DCs, including single DCs or DCs forming an IS, to a fractionation that yielded cytoplasmic and nuclear fractions of the cells 42 . These fractions were then analyzed by immunoblot with an antibody specific for GFP. In DCs that formed an IS, FOXO1 was localized largely in the cytoplasmic fraction, whereas in the single DCs, FOXO1 was present predominantly in the nuclear fraction (Fig. 8d) . Finally, we studied whether inhibition of Akt1 prevents FOXO1 translocation to the cytoplasm in DCs forming an IS. Single DCs or DCs that were previously induced to form IS were transferred to serum-free medium. Half of these cells were treated with the PI(3)K inhibitor LY294002 and the other half were kept untreated for a similar period. Immunofluorescence analysis revealed that when PI(3)K and downstream target Akt were inhibited, FOXO1 remained largely in the nucleus of the DCs, even when these cells formed an IS (Fig. 8e) . These results suggest that Akt1 regulates the translocation of FOXO1 to the cytoplasm of DCs after IS formation ( Supplementary Fig. 9 online) .
FOXO1-GFP into DCs 41 and then allowed the transfected DCs to form an IS with T cells. Subsequently, we transferred the cells to serum-free medium and compared the percentage of FOXO1-GFP in the cytoplasm of single DCs versus DCs forming an IS. Thirty percent of single DCs presented FOXO1-GFP in the cytoplasm
CD40 contributes to IS(DC) antiapoptotic signaling
The IS(DC) includes receptors such as the integrin LFA-1 (a L b 2 ) 12 and the co-stimulatory molecule CD40 9 . Therefore, we studied the ability of LFA-1 and CD40 to induce Akt1 activation. We induced clustering of either CD40 or LFA-1 with specific antibodies and then analyzed the activation of Akt1. In contrast to LFA-1, which failed to induce activation of Akt1 (data not shown), cross-linking of CD40 induced Akt1 phosphorylation (Fig. 9) . As stimulation of CD40 induces extended survival in DCs [43] [44] [45] , these results suggest that CD40 may be an important contributor to the antiapoptotic signaling induced from the IS(DC) (Supplementary Fig. 9 ).
DISCUSSION
Several groups have shown that DCs become apoptotic and die in the lymph nodes 27, 28 . As the activation of a T cell in the lymph node involves the formation of an IS, a structure that reflects the longlasting interaction that takes place between a DC and a T cell 4, 6, 7, 29, 30 , we hypothesized that the IS(DC) could act as a molecular device that relays antiapoptotic signals to the DC. Here we have provided experimental evidence supporting this hypothesis, and we suggest a mechanism whereby IS formation may inhibit DC apoptosis.
The observation that DCs exhibit a higher susceptibility to apoptosis than CD4 T cells when placed under serum-free conditions facilitated the experimental testing of this hypothesis in vitro. Under serum-free conditions, the percentage of DCs undergoing apoptosis in vitro was reduced by almost 60% in the DCs that formed IS compared to single DCs. Apoptosis was probably mitochondrial (caspase 9 dependent 20 ) and not caused by death receptors (caspase 8 dependent 20 ) because it was inhibited by a caspase 9 inhibitor but was not affected by a caspase 8 inhibitor (data not shown). Consistent with previous results, we also observed IS formation by DCs in the absence of antigen 46, 47 . IS formation conferred protection against apoptosis in both antigen-specific and non-antigen-specific DC-T cell conjugates. In addition, IS formation with naive or memory T cells suppressed DC apoptosis.
Consistent with a role for the IS(DC) as a signaling platform that regulates survival in the DC, we observed phosphotyrosine staining and Akt1 activation in this region. However, Akt1 does not seem to be the only molecule mediating the prosurvival effects of the IS(DC), because these effects were not completely abrogated when PI(3)K and Akt were inhibited. In this context, it has been suggested that Notch1, another receptor located at the IS(DC), may inhibit the apoptosis of DCs by inducing activation of Akt and STAT3, a transcription factor that promotes cell survival 51 . As Akt1 has also been shown to be activated at the IS(T cell) 36 , it is possible that this kinase could regulate prosurvival signaling from the IS(T cell). Further supporting an antiapoptotic role for the IS(DC), two effectors of Akt1, namely NF-kB and FOXO1, which transduce prosurvival and proapoptotic signals, respectively 22, [24] [25] [26] , were affected in opposite fashion upon IS(DC) formation. IS(DC) formation induced translocation of NF-kB to the nucleus, where this factor may potentially regulate transcription of prosurvival genes, including Bcl-2 (refs. 21, 24) . IS(DC) formation also induced translocation of FOXO1 from the nucleus to the cytoplasm of the DCs, a process that inactivates this transcription factor and blocks its ability to upregulate expression of the proapoptotic Bcl-2 member Bim in DCs 22, [24] [25] [26] . Therefore, our results clearly indicate that IS(DC) formation results in the activation of intracellular signals that suppress DC apoptosis.
Among the surface receptors of the IS(DC), CD40 but not LFA-1 cross-linking potently activated Akt1. As CD40 is known to induce survival in DCs [43] [44] [45] , this result suggests that this receptor may contribute to the antiapoptotic effects induced by the IS(DC). However, additional surface receptors and signaling molecules should be analyzed to completely understand the mechanism(s) through which IS(DC) induce survival. Finally, our observation that IS formation protects DCs from apoptosis in the lymph node indicates that this mechanism also operates in vivo. In sum, our results indicate a new function for the IS that affects DCs and that can be important for proper activation of T cells and for subsequent immune responses.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureimmunology/.
Accession codes. UCSD-Nature Signaling Gateway (http://www. signaling-gateway.org): A000031, A000249 and A000944. Preparation of human polyclonal non-antigen-specific memory and naive CD4 T cells and PPD-specific CD4 T cells. Naive human CD45RA + C-D45RO À CD4 T cells were obtained from umbilical cord blood. Flow cytometry showed that 70-80% of the T cells were CD45RA + . Resting memory CD4 T cells were isolated from human PBMCs. CD4 T cells were selected using a CD4 negative-selection kit that includes a hapten-antibody 'cocktail' of anti-CD8, anti-CD11b, anti-CD16, anti-CD19, anti-CD36, anti-CD56 (Miltenyi Biotech) and anti-hapten magnetic beads (Miltenyi). To prepare CD4 + PPDspecific clones, we previously selected donors whose T cells responded to PPD or tetanus toxoid antigens. For this purpose, PBMCs of selected donors were cultured with PPD (final concentration, 50 U/ml) for 6 d. After stimulation, cellular proliferation was evaluated by incorporation of [ 3 H]thymidine into DNA. PBMCs were seeded at 2 Â 10 6 cells per well in triplicate U-bottom, 96-wells plates with RPMI-1640 containing 10% human AB serum. The results were expressed as lymphocyte stimulation index (LSI), which is the geometric mean counts per minute (c.p.m.) of the cells incubated with antigen divided by the geometric mean c.p.m. of the cells with medium alone. As a positive control of proliferation we used pokeweed mitogen (Sigma) at 4 mg/ml. Donors with LSI 4 5 for PPD were selected for further experiments. To obtain CD4 PPDspecific T cell clones from samples from the selected donors, PBMCs were stimulated overnight with PPD, and antigen-specific IFN-g-producing CD4 + T cells were isolated using a cell enrichment and detection kit (Miltenyi). Antigen-specific T cell clones were cultivated in 10% AB serum in RPMI with IL-2 (50 U/ml) addition every second day.
In vitro induction of IS formation between DC and CD4 T cells IS formation between human or mouse DCs and T cells was induced as reported before 17, 19 .
Briefly, DCs and CD4 T cells (ratio 1 DC:5 CD4 T cells) were incubated in complete medium (10% FCS in RPMI for human cells that established allogeneic interactions and for mouse cells; 10% human AB serum in RPMI for human cells that established antigen-specific interactions). Subsequently, the cells were centrifuged (50g, 5 min) in a conical tube and then incubated in the corresponding complete medium for another 2 h to foster IS formation.
In vitro induction of apoptosis. Single DCs or DCs forming IS were transferred to 0.1% BSA in RPMI plus 20 mM HEPES for 10 h. At the end of this period, apoptotic parameters in the cells were examined either by staining of the nuclei with Hoechst 33342 or by analyzing phosphatidylserine externalization using annexin V staining. To stain the nuclei with Hoechst 33342, the DCs were fixed in 4% formaldehyde in PBS and then permeabilized in cold methanol for 20 min. 31 . The percentage of inhibition of apoptosis in control and LY294002-treated conjugates (Fig. 5b, left) was calculated as follows: % apoptosis of single DCs-% apoptosis of DCs forming IS / % apoptosis of single DCs.
Purification and labeling of mouse DCs and CD4 T cells. Mouse DCs were immunomagnetically purified (97% CD11c + ) from spleens of donor mice (Miltenyi). CD4 + T cells from lymph nodes and spleens of OT-II transgenic mice were purified by negative immunomagnetic cell sorting (Miltenyi). Purity was typically more than 90%. Mouse DCs or CD4 OTII T cells used in the in vivo studies were labeled for 30 min at 37 1C with 5 mM CMFDA, CFSE or SNARF-1 in 01% BSA in PBS. Control experiments showed that OVA peptidepulsed DCs induced activation and proliferation of OTII CD4 T cells in vitro ( Supplementary Fig. 2 ).
Injection of DCs, CD4 T cells and FLIVO in C57BL/6 mice. CMFDA-labeled splenic DCs (2 Â 10 6 ) were pulsed with OVA 323-339 peptide (1 mg/ml) in RPMI for 1 h. Subsequently, the DCs were suspended in 50 ml RPMI and injected subcutaneously along with LPS (1 mg/ml) into the hind footpad of recipient C57BL/6 mice (1 Â 10 6 DCs per footpad). After 18 h, 5 Â 10 6 SNARF1-labeled OT-II CD4 + T cells were injected into the tail vein of the mice. After another 17 h, the mice were injected intravenously with 8 mg of FLIVO dissolved in 20% DMSO and 80% PBS. Red SR-FLIVO or green FAM-FLIVO were injected when CMFDA or SNARF1 labeled DCs, respectively, were used. After another 60 min to allow the reagent to stain apoptotic DCs, mice were put to death. The popliteal lymph nodes were extracted from the mice, trimmed free of fat and then analyzed by two-photon microscopy.
Two-photon microscopy of lymph nodes. Isolated popliteal lymph nodes were fixed with paraformaldehyde (30 min), washed in PBS and then immersed in fluorescence mounting medium (Prolong Gold, Molecular Probes) between two glass coverslips to allow visualization from both sides of the lymph node. Imaging was carried out with a Â20 magnification, oil-immersion objective (numerical aperture 1.20) in a Leica confocal inverted microscope (TCS-SP2 AOBS spectral system) equipped with a wideband, mode-locked Ti:sapphire two-photon excitation laser (Mai Tai, Spectra-Physics). Optimal two-photon excitation of the three fluorochromes was achieved at 856 nm wavelength and spectral detection was at 510-540 nm (for CMFDA and FAM-FLIVO) and 560-600 nm (SNARF1 and SR-FLIVO). Detector slits were configured to minimize cross-talk between channels. Lymph nodes were thoroughly scanned from both sides up to a depth of 200-300 mm with a z spacing of 2 mm.
Analysis of apoptotic DCs in lymph nodes. A fluorescent-dye labeled form of FLIVO was injected intravenously in mice to label apoptotic DCs in the lymph nodes. Two-photon microscopy optical section stacks obtained from the analysis of the lymph node, showing DCs alone or forming IS, were examined for the presence of FLIVO staining using Leica Confocal Software (LCS) (Supplementary Fig. 5 ). To quantify the amount of FLIVO incorporated by the cells labeled with the fluorescent cell tracker probes (CMFDA or SNARF1), we used the LCS profile quantification tool. In each cell to be analyzed, we traced several linear regions of interest (ROI), and finally selected the ROI providing the maximum intensity of FLIVO staining for each cell. Subsequently, we obtained graphs with the intensity profiles of the SNARF1/FAM-FLIVO or the CMFDA/SR-FLIVO pair. Although in the description below we focus on the latter pair, which we used predominantly in this study, similar results were obtained when we used SNARF1/FAM-FLIVO in the experiments (data not shown). Analysis of the SR-FLIVO and CMFDA intensity profiles of multiple cells showed that there was no leakage between the two channels. Therefore, we decided to use the value of maximum amplitude of the SR-FLIVO, provided automatically by the LCS, as an index of the incorporation of SR-FLIVO and, consequently, of the apoptotic status of the cell analyzed ( Supplementary Figs. 4 and 5). From this value we subtracted the value of SR-FLIVO channel background in the field where the cell was positioned, a background that was negligible in most cases. For the practical analysis shown in Figure 3 , we considered a live DC or T cell to be any that showed a value of maximum amplitude of the SR-FLIVO channel equal or lower than 30 ( Supplementary Fig. 5 ). This restrictive value was chosen based on the results shown in Supplementary Figures 4 and 5 , which indicate that DCs or T cells that are negative for SR-FLIVO staining are also identified as live cells according to Hoechst staining. DCs or T cells that had maximum amplitude SR-FLIVO values above 30 were considered apoptotic. The percentages of protection obtained when we measured absolute values of maximum intensities of SR-FLIVO were similar to those obtained when we measured the ratio maximum amplitude SR-FLIVO over the maximum amplitude CMFDA (data not shown).
Immunofluorescence and confocal microscopy. Immunofluorescence was performed as described 31, 48, 50 . Briefly, cells were plated at 37 1C for 30 min onto coverslips coated with PLL (20 mg/ml). Then the cells were fixed in 4% paraformaldehyde in PBS (10 min at room temperature) and permeabilized with 0.2% Triton X-100 (10 min at room temperature). When the cells were processed for immunofluorescence, they were first treated, to block antibody Fc receptor binding, either with 50 mg/ml of human IgG (15 min) in the case of human cells or with anti-mouse CD16/32 in the case of mouse cells, and then, to block nonspecific binding, with 1% BSA (15 min). Subsequently, the cells were stained with FITC or Texas red-conjugated phalloidin or with suitable primary or secondary antibodies. Before mounting, the samples were extensively washed with PBS and distilled water. Coverslips were mounted in fluorescence mounting medium (Dako). Laser-scanning confocal microscopy was performed with argon and helium/neon laser beams and an Ultra-spectral Leica TCS-SP2-AOBS inverted epifluorescence microscope using oil immersion objectives. GFP-labeled cells were analyzed with the FITC fluorescent channel. In Figure 7 , to quantify Texas Red fluorescence intensity in the DCs nucleofected with siRNA control or siRNA for FOXO1, regions of interest (ROI) were selected using a contour selection tool and then, within this ROI, fluorescence was quantified using the confocal microscope software. Set parameters were conserved during all acquisitions both for siRNA control and siRNA FOXO1. Red fluorescence intensity was quantified in 50 ROIs.
Flow cytometry. Flow cytometry was performed as described 50 . Briefly, human and mouse cells were treated with human IgG (50 mg/ml) or anti-CD16/32 (0.5 mg per million cells), respectively, to block antibody binding to Fc receptors. Subsequently, cells were incubated at 4 1C with appropriate primary mAbs (anti-CD1a, anti-CD14, anti-HLA-DR, anti-CCR7, anti-CD83 or anti-CD69). The cells were then analyzed on a FACScan cytometer using CellQuest software. Background fluorescence was evaluated with an irrelevant, isotypematched mAb.
